Skip to main content
NEOGENOMICS INC logo

NEOGENOMICS INC — Investor Relations & Filings

Ticker · NEO ISIN · US64049M2098 LEI · 549300KN62PPGHBVXB46 US Human health and social work activities
Filings indexed 1,049 across all filing types
Latest filing 2026-04-28 Interim / Quarterly Rep…
Country US United States of America
Listing US NEO

About NEOGENOMICS INC

https://neogenomics.com/

NeoGenomics, Inc. is a cancer diagnostics company specializing in genetics testing, oncology data solutions, and pharmaceutical services. It provides a comprehensive menu of over 500 tests for both solid tumors and hematologic cancers, supporting oncologists and healthcare providers with diagnostic, prognostic, and predictive insights for personalized patient care. The company's testing modalities include immunohistochemistry (IHC), flow cytometry, fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), and comprehensive genomic profiling (CGP). Additionally, NeoGenomics partners with biopharmaceutical companies to support drug development, clinical trials, and biomarker discovery, leveraging its extensive multi-modal dataset to offer advanced oncology data solutions.

Recent filings

Filing Released Lang Actions
10-Q - NEOGENOMICS INC (0001077183) (Filer)
Interim / Quarterly Report
2026-04-28 English
SCHEDULE 13G/A - NEOGENOMICS INC (0001077183) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - NEOGENOMICS INC (0001077183) (Filer)
Director's Dealing
2026-03-04 English
4 - NEOGENOMICS INC (0001077183) (Filer)
Director's Dealing
2026-03-04 English
4 - NEOGENOMICS INC (0001077183) (Filer)
Director's Dealing
2026-03-04 English
4 - NEOGENOMICS INC (0001077183) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.